These emerging medications , including Semaglutide , a similar compound, and Zaxig Body Protection Compound , represent a important advancement in addressing type 2 the condition and supporting weight management. They operate by emulating the body’s natural incretin GLP-1 , enabling to regulate blood sugar and reduce cravings. Each medication has